Company Filing History:

5 out of 24

Astra Pharmaceuticals Limited

patents

Astra Zeneca U.k. Limited

patents

Years Active: 1986-2001

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6303613 - Aminopyrimidine derivatives, processes for their preparation, compositions containing them and their use as pharmaceuticals (2001-10-16),

2. 6248745 - Pharmaceutical combination comprising a COX-2 inhibitor and a iNOS inhibitor (2001-06-19),

3. 6211189 - Amino-spiro-quinazoline compounds (2001-04-03),

4. 6100246 - Spiro-piperidine derivatives as inhibitors of nitric oxide synthase (2000-08-08),

5. 6083952 - Compounds (2000-07-04),

6. 6063789 - Aminoisoquinolines and aminotheinopyridine derivatives and their use as (2000-05-16),

7. 6046191 - Combination (2000-04-04),

8. 5883102 - Pharmaceutically active compounds (1999-03-16),

9. 4868306 - Compounds (1989-09-19),

10. 4791216 - Para ethyl amino phenol pharmaceutical compounds (1988-12-13),

11. 4686217 - Calcium antagonist 2-fluoroalkyl-1,4-dihydropyridines (1987-08-11),

12. 4657929 - Compounds (1987-04-14),

13. 4607041 - Antihypertensive 2-phenyl Hantzsch dihydropyridines (1986-08-19),

Title: The Innovative Contributions of Alan C Tinker

Introduction: Alan C Tinker is an esteemed inventor based in Loughborough, United Kingdom. With an impressive portfolio of 13 patents, Tinker's work primarily focuses on pharmaceutical innovations that aim to enhance treatment options for various medical conditions. His contributions to the field exemplify the significant impact of inventive thinking in addressing healthcare challenges.

Latest Patents: Among his latest patents, Tinker developed novel aminopyrimidine derivatives along with processes for their preparation. These innovative compounds are designed for use in pharmaceuticals. Additionally, he introduced a pharmaceutical combination that includes a COX-2 inhibitor and an iNOS inhibitor. This invention highlights the method of co-administration of these inhibitors for treating inflammation and inflammatory disorders, marking a valuable advancement in therapeutic strategies.

Career Highlights: Alan C Tinker has had a notable career working with prominent companies in the pharmaceutical sector, including Astra Pharmaceuticals Limited and Fisons Ltd. Throughout his tenure, he has contributed significantly to drug formulation and development, showcasing his commitment to improving patient outcomes through innovation.

Collaborations: Tinker has collaborated with talented individuals in his field, including coworkers Peter Richard Hamley and Thomas McInally. These partnerships have allowed for the cross-pollination of ideas, further fueling the ingenuity and success of their projects.

Conclusion: Alan C Tinker is a remarkable inventor whose work continues to influence the pharmaceutical industry. With a notable history of patents and collaborations, he represents the forward-thinking spirit necessary for developing new medical therapies. His latest innovations are a testament to his dedication to advancing health solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com